Vivoryon Therapeutics N.V. (05Y.F)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Frank T. Weber M.D. | Chairman of the Management Board, CEO, Chief Medical Officer & Executive Director | 250.32k | -- | 1960 |
| Ms. Anne Doering C.F.A. | CSO & Investor Relations Officer, CFO, Member of the Management Board and Executive Director | 219.12k | -- | 1973 |
| Dr. Michael Schaeffer Ph.D. | Chief Business Officer, Member of the Management Board & Executive Director | 325k | -- | 1969 |
| Dr. Manuela Bader | Director of Investor Relations & Communications | -- | -- | -- |
| Dr. Konrad Glund | Co-Founder & Advisor | 222.11k | -- | 1953 |
| Dr. Hendrik Liebers | Advisor | 319.2k | -- | 1971 |
Vivoryon Therapeutics N.V.
- Sector:?
- Healthcare
- Industry:? Biotechnology
- Full Time Employees:?
- 15
Description
Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta. The company's lead product candidate is PQ912, a nanomolar QPCT inhibitor that has completed Phase IIb clinical trials for use in the treatment of Alzheimer's disease. In addition, the company is developing a monoclonal antibody PBD-C06 is for N3pE-Abeta. Vivoryon Therapeutics N.V. has a collaboration agreement with Nordic Bioscience for the clinical development of PQ912 for Alzheimer's disease; and research collaboration with the Fraunhofer Institute for cell therapy and immunology, as well as a strategic regional licensing partnership with Simcere Pharmaceutical Group Ltd. to develop and commercialize medicines targeting the neurotoxic amyloid species N3pE (pGlu-Abeta) to treat Alzheimer's disease. Vivoryon Therapeutics N.V. was founded in 1997 and is headquartered in Halle, Germany.
Corporate Governance
Upcoming Events
September 12, 2024 at 5:00 AM UTC
Vivoryon Therapeutics N.V. Earnings Date
Recent Events
Recent Events Information Not Available